Elaine Zhou1, Benjamin Roland Hauser, Youn Hee Jee. 1. Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA.
Abstract
PURPOSE OF REVIEW: Short stature is a common clinical manifestation in children. Yet, a cause is often unidentifiable in the majority of children with short stature by a routine screening approach. The purpose of this review is to describe the optimal genetic approach for evaluating short stature, challenges of genetic testing, and recent advances in genetic testing for short stature. RECENT FINDINGS: Genetic testing, such as karyotype, chromosomal microarray, targeted gene sequencing, or exome sequencing, has served to identify the underlying genetic causes of short stature. When determining which short stature patient would benefit from genetic evaluation, it is important to consider whether the patient would have a single identifiable genetic cause. Specific diagnoses permit clinicians to predict responses to growth hormone treatment, to understand the phenotypic spectrum, and to understand any associated co-morbidities. SUMMARY: The continued progress in the field of genetics and enhanced capabilities provided by genetic testing methods expands the ability of physicians to evaluate children with short stature for underlying genetic defects. Continued effort is needed to elaborate new genetic causes of linear growth disorders, therefore, we expand the list of known genes for short stature, which will subsequently increase the rate of genetic diagnosis for children with short stature.
PURPOSE OF REVIEW: Short stature is a common clinical manifestation in children. Yet, a cause is often unidentifiable in the majority of children with short stature by a routine screening approach. The purpose of this review is to describe the optimal genetic approach for evaluating short stature, challenges of genetic testing, and recent advances in genetic testing for short stature. RECENT FINDINGS: Genetic testing, such as karyotype, chromosomal microarray, targeted gene sequencing, or exome sequencing, has served to identify the underlying genetic causes of short stature. When determining which short stature patient would benefit from genetic evaluation, it is important to consider whether the patient would have a single identifiable genetic cause. Specific diagnoses permit clinicians to predict responses to growth hormone treatment, to understand the phenotypic spectrum, and to understand any associated co-morbidities. SUMMARY: The continued progress in the field of genetics and enhanced capabilities provided by genetic testing methods expands the ability of physicians to evaluate children with short stature for underlying genetic defects. Continued effort is needed to elaborate new genetic causes of linear growth disorders, therefore, we expand the list of known genes for short stature, which will subsequently increase the rate of genetic diagnosis for children with short stature.
Authors: Mariana F A Funari; Juliana S de Barros; Lucas S Santana; Antonio M Lerario; Bruna L Freire; Thais K Homma; Gabriela A Vasques; Berenice B Mendonca; Mirian Y Nishi; Alexander A L Jorge Journal: Clin Genet Date: 2019-07-04 Impact factor: 4.438
Authors: Nadine N Hauer; Bernt Popp; Eva Schoeller; Sarah Schuhmann; Karen E Heath; Alfonso Hisado-Oliva; Patricia Klinger; Cornelia Kraus; Udo Trautmann; Martin Zenker; Christiane Zweier; Antje Wiesener; Rami Abou Jamra; Erdmute Kunstmann; Dagmar Wieczorek; Steffen Uebe; Fulvia Ferrazzi; Christian Büttner; Arif B Ekici; Anita Rauch; Heinrich Sticht; Helmuth-Günther Dörr; André Reis; Christian T Thiel Journal: Genet Med Date: 2017-10-12 Impact factor: 8.822
Authors: Reena Perchard; Philip George Murray; Antony Payton; Georgina Lee Highton; Andrew Whatmore; Peter Ellis Clayton Journal: J Endocr Soc Date: 2020-09-10